Ovarian cancer drug to enter phase II clinical trial
An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial.
May 5, 2023
0
92
Endocrine System Diseases: News and Research on Ovarian Neoplasms
MeSH tree: C19.391.630.705
Study highlights racial disparities in ovarian cancer risk for women
A new Fred Hutchinson Cancer Center study in the journal Obstetrics & Gynecology investigated how endometriosis, uterine leiomyomas (also known as fibroids) and a common intervention for these conditions—hysterectomy—changed ...
May 4, 2023
0
43
Cancer therapy: Gene silencing of cytoskeleton-associated protein 5 in genetically unstable cancer cells
The therapeutic potential of microtubule-associated protein targets for cancer therapy is a largely unexplored research area due to a lack of target-specific agents. Sushmita Chatterjee and a research team in nanomedicine, ...
Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines
Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for hereditary breast and ovarian cancer (HBOC) or Lynch syndrome, 39.2% would not have qualified for genetic ...
Apr 18, 2023
0
51
Research finds removing ovaries at benign hysterectomy carries health risks
An emulated target trial of more than 140,000 women in Denmark found that removing the ovaries at benign hysterectomy was associated with increased risk for cardiovascular disease in younger women and cancer in older women ...
Apr 18, 2023
0
61
Pregnancy-associated cancers tied to higher five-year mortality
Pregnancy-associated cancers are associated with increased five-year mortality, according to a study published online April 6 in JAMA Oncology.
Apr 11, 2023
0
39
How social media can help to understand treatment experiences of survivors of rare cancers
Cancer specialists have taken a novel path to advance their research—tapping into a Facebook group for rare ovarian cancer insights.
Apr 6, 2023
0
31
Johnson & Johnson proposes $8.9 bn settlement of talc cancer claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
Apr 5, 2023
0
63
All hormonal contraceptives increase breast cancer risk: Study
All hormonal contraceptives carry a slightly increased risk of breast cancer, including the increasingly popular progestogen-only pills, according to a study published on Tuesday.
Mar 25, 2023
0
236
Phase 1 study: New medicine extends terminally-ill cancer patients' lives
A promising cancer drug that targets only cancer cells has been developed by researchers from the Norwegian University of Science and Technology (NTNU) and a university spin-off company, APIM Therapeutics.
Mar 22, 2023
0
147
